| before pathway implementation | after pathway implementation, without personal briefing | after pathway implementation and personal briefing |
---|---|---|---|
 | (n = 132) | (n = 70) | (n = 58) |
surgery performed by trial investigator | 25% | 30% | 22% |
median duration of surgery | 88 min | 83 min | 87 min |
median duration of indoor treatment | 9 days | 9 days | 9 days |
patients with PCCL 1„0" | 42% | 60% | 55% |
patients with PCCL 1„3" or„4" | 34% | 27% | 24% |